TRABD maintains mitochondrial homeostasis and protects against ischemia reperfusion-induced renal tubular injury.

Front Cell Dev Biol · 2025 · PMC12329661 · PMID 40778267

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In addition, MFN2 exhibits a decreasing trend in TRABD KO cells following CCCP treatment.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.